JP2019507182A5 - - Google Patents

Download PDF

Info

Publication number
JP2019507182A5
JP2019507182A5 JP2018557295A JP2018557295A JP2019507182A5 JP 2019507182 A5 JP2019507182 A5 JP 2019507182A5 JP 2018557295 A JP2018557295 A JP 2018557295A JP 2018557295 A JP2018557295 A JP 2018557295A JP 2019507182 A5 JP2019507182 A5 JP 2019507182A5
Authority
JP
Japan
Prior art keywords
acid
composition
use according
chemerin
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018557295A
Other languages
English (en)
Japanese (ja)
Other versions
JP6924211B2 (ja
JP2019507182A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/014605 external-priority patent/WO2017127827A1/en
Publication of JP2019507182A publication Critical patent/JP2019507182A/ja
Publication of JP2019507182A5 publication Critical patent/JP2019507182A5/ja
Priority to JP2021125537A priority Critical patent/JP2021169531A/ja
Application granted granted Critical
Publication of JP6924211B2 publication Critical patent/JP6924211B2/ja
Priority to JP2023029552A priority patent/JP7432028B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018557295A 2016-01-22 2017-01-23 炎症を処置するための化合物および方法 Active JP6924211B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021125537A JP2021169531A (ja) 2016-01-22 2021-07-30 炎症を処置するための化合物および方法
JP2023029552A JP7432028B2 (ja) 2016-01-22 2023-02-28 炎症を処置するための化合物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662286070P 2016-01-22 2016-01-22
US62/286,070 2016-01-22
PCT/US2017/014605 WO2017127827A1 (en) 2016-01-22 2017-01-23 Compounds and methods for treating inflammation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021125537A Division JP2021169531A (ja) 2016-01-22 2021-07-30 炎症を処置するための化合物および方法

Publications (3)

Publication Number Publication Date
JP2019507182A JP2019507182A (ja) 2019-03-14
JP2019507182A5 true JP2019507182A5 (https=) 2020-03-05
JP6924211B2 JP6924211B2 (ja) 2021-08-25

Family

ID=57963487

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018557295A Active JP6924211B2 (ja) 2016-01-22 2017-01-23 炎症を処置するための化合物および方法
JP2021125537A Pending JP2021169531A (ja) 2016-01-22 2021-07-30 炎症を処置するための化合物および方法
JP2023029552A Active JP7432028B2 (ja) 2016-01-22 2023-02-28 炎症を処置するための化合物および方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021125537A Pending JP2021169531A (ja) 2016-01-22 2021-07-30 炎症を処置するための化合物および方法
JP2023029552A Active JP7432028B2 (ja) 2016-01-22 2023-02-28 炎症を処置するための化合物および方法

Country Status (7)

Country Link
US (3) US11197906B2 (https=)
EP (1) EP3405208B1 (https=)
JP (3) JP6924211B2 (https=)
AU (1) AU2017210118B2 (https=)
CA (1) CA3012190A1 (https=)
ES (1) ES2805037T3 (https=)
WO (1) WO2017127827A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014168721A2 (en) 2013-04-12 2014-10-16 Tufts Medical Center Methods and systems for designing and/or characterizing soluble lipidated ligand agents
EP3405208B1 (en) 2016-01-22 2020-04-29 Tufts Medical Center, Inc. Compounds and methods for treating inflammation
JP7251036B2 (ja) * 2018-06-28 2023-04-04 ポーラ化成工業株式会社 皮膚老化改善剤のスクリーニング方法
US12559523B2 (en) 2019-08-01 2026-02-24 Okyo Pharma Limited Compositions comprising chemerin analogs and methods of use
EP4522118A2 (en) * 2022-05-12 2025-03-19 Okyo Pharma Limited Chemerin-containing formulation for treating dry eye disease

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416738B1 (en) 1973-12-07 2002-07-09 Neorx Corporation Pretargeting methods and compounds
US5200473A (en) 1988-03-25 1993-04-06 Jeanneret Gris Gilbert Chelating resins and method for their use in the extraction of metal ions
JP3507486B2 (ja) 1991-03-15 2004-03-15 アムジエン・インコーポレーテツド 顆粒球コロニー刺激因子の肺内投与
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
CN1355690A (zh) 1999-04-16 2002-06-26 奥赛尔股份有限公司 一种延长可溶性病毒特异性配体在粘膜上半寿期的方法
IL160142A0 (en) 2001-08-17 2004-06-20 Anosys Inc Methods and compounds for the targeting of protein to exosomes
US7169892B2 (en) 2003-01-10 2007-01-30 Astellas Pharma Inc. Lipid-peptide-polymer conjugates for long blood circulation and tumor specific drug delivery systems
WO2004084950A2 (en) 2003-03-24 2004-10-07 Case Western Reserve University Cell targeting methods and compositions
WO2005121755A1 (en) 2004-06-14 2005-12-22 Commonwealth Scientific And Industrial Research Organisation Cell free g-protein coupled receptor and ligand assay
MX2007004676A (es) 2004-10-27 2007-11-14 Univ Denver Analogos de la hormona adrenocorticotropica y metodos relacionados.
PL1891446T3 (pl) 2005-06-14 2013-08-30 Cellzome Gmbh Sposób identyfikacji nowych związków oddziałujących z enzymami
US8242058B2 (en) 2006-07-21 2012-08-14 Wisconsin Alumni Research Foundation Reagents and methods for appending functional groups to proteins
JP2010229093A (ja) 2009-03-27 2010-10-14 Banyu Pharmaceut Co Ltd 新規ChemerinRアゴニスト
GB0914110D0 (en) 2009-08-12 2009-09-16 Medical Res Council Peptide libraries
WO2011034887A2 (en) 2009-09-15 2011-03-24 The Brigham And Women's Hospital, Inc. A method for treating neuropathic pain
AU2011213631B2 (en) 2010-02-08 2015-05-14 Board Of Regents Of The University Of Nebraska Biomineral and metal binding liposomes, their synthesis, and methods of use thereof
US8883177B2 (en) 2011-06-28 2014-11-11 Nian Wu Pharmaceutical compositions for parenteral administration
HK1202064A1 (en) * 2011-10-13 2015-09-18 托马斯.盖德克 Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions
WO2014168721A2 (en) 2013-04-12 2014-10-16 Tufts Medical Center Methods and systems for designing and/or characterizing soluble lipidated ligand agents
EP3405208B1 (en) 2016-01-22 2020-04-29 Tufts Medical Center, Inc. Compounds and methods for treating inflammation

Similar Documents

Publication Publication Date Title
JP2019507182A5 (https=)
US8324276B2 (en) Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
Han et al. Vitamin D in liver diseases: from mechanisms to clinical trials
Hjorth et al. Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers
AU2004269903B2 (en) The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
Liu et al. CD31: beyond a marker for endothelial cells
CN109562129B (zh) 含有从脂肪来源的干细胞分离的外排体作为活性成分的用于预防或治疗肺纤维化的组合物
JP2019048843A5 (https=)
AU2026202508A1 (en) Matrix bound vesicles (mbvs) containing il-33 and their use
JP7432028B2 (ja) 炎症を処置するための化合物および方法
US20120277317A1 (en) Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-related diseases
JP2018527322A5 (https=)
IL294736A (en) Preparations including 15-hydroxy-eicosapentaenoic acid and methods of using them
IL316406A (en) Lipid-modified relaxin B peptide chains and their medical use
WO2014126176A1 (ja) 炎症性疾患の予防又は治療用組成物
CN102286397B (zh) 多菌发酵剂和用于抗动脉粥样硬化的多菌发酵乳品及其生产方法
ITMI20130354A1 (it) Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
JP2018537513A5 (https=)
JP2017536380A (ja) 15−hepeを含む組成物、およびそれを用いて線維症を処置または防止する方法
de Oliveira et al. AT-RvD1 modulates the activation of bronchial epithelial cells induced by lipopolysaccharide and Dermatophagoides pteronyssinus
JP2016210814A (ja) カルボン酸フェニルケトン化合物およびその薬学的使用
KR20190060492A (ko) 그래핀 양자점을 포함하는 항염증용 조성물
JP2015521611A5 (https=)
MY190709A (en) A polypeptide from mormodica charantia for use for the regulation of genes related to inflammation, lipid and glucose metabolism
CN103476405A (zh) 舒张性充血性心力衰竭治疗剂